Trial · NCT01717742
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time to Hospital Discharge | up to 4 months | Time from insertion of the chest drain to discharge from hospital. |
| Secondary | Time to Meeting Discharge Criteria | up to 4 months | Time from insertion of the chest drain to meeting discharge criteria. Discharge criteria: * Chest tube removed * No fever \[temperature less than 38°C\] * Normal respiratory rate forage * No hypoxia * Drinking fluids wel |
| Secondary | Time to Drain Removal | up to 4 months | Time from drain insertion to drain removal. |
| Secondary | Duration of Fever After Intervention | up to 4 months | Duration of fever (defined as temperature \>38 degrees celsius taken by any method) from insertion of the chest drain until resolution. |
| Secondary | Number of Participants With Need for Ventilatory Support or Non-invasive Ventilation Following the Intervention | up to 4 months | Number of Participants with need for any kind of ventilatory support or any kind of non-invasive ventilation right after the intervention. |
| Secondary | Number of Participants With Serious Bleeding | up to 4 months | Number of Participants who had intrapleural bleeding resulting in a drop in hemoglobin of greater than 20 g/L or needing a transfusion. |
| Secondary | Number of Participants With Further Interventions | up to 4 months | Number of participants who needed further intervention such as placement of another chest drain (by any technique) or surgical intervention such as thoracotomy and decortication, video-assisted thorascopic surgery, or pneumonectomy. |
| Secondary | Number of Participants With Hospital Readmission | 3 months post-discharge | Number of Participants who had any hospital readmission after discharge from hospital for initial treatment for pleural empyema within three months related to pleural empyema or its treatment. |
| Secondary | Cost of the Hospitalization | up to 4 months | An economic evaluation will compare the relative costs of DNase-tPA with tPA alone in previously well children who present with pleural empyema, using patient-level data from the trial. |
| Secondary | Mortality | up to 4 months | Mortality from any cause during the hospitalization for empyema. |
| Other | Chest Radiography | 7 days after drain removal | The radiograph closest to the time of drain removal will be reviewed by a blinded study radiologist to determine the percentage of hemithorax occupied using a 5 point ordinal scale utilized in previous studies ranging from no fluid present to fluid occupying \>75% of the most affected hemithorax. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01717742/registered